Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-13

FDA Approved: AURLUMYN — Original Application (BTG International Inc)

View source ↗

Summary

FDA approved AURLUMYN (iloprost) through an original NDA from BTG International Inc. The approval establishes a new iloprost product for its indicated use in pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AURLUMYN (ILOPROST)

Snippet

ORIG AP for AURLUMYN (ILOPROST)